权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Cleavage of Bcl-xL by Caspases contributes to cell death in vivo

Caspases 对 Bcl-xL 的裂解导致体内细胞死亡

基本信息

批准号：
9050122
负责人：
Jason Huska
金额：
$ 4.36万
依托单位：
JOHNS HOPKINS UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2016
资助国家：
美国
起止时间：
2016-01-01 至 2017-12-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9050122
关键词：
Address Affect Affinity Age Aging Animals Apoptosis Apoptotic Architecture Atrophic Autoimmune Diseases BCL-2 Protein BCL2 gene Binding Body Weight decreased Bone Marrow CD8B1 gene Caspase Cell Death Cell Death Process Cells Cellularity Cessation of life Chimera organism Cleaved cell Communicable Diseases Cues Cytotoxic T-Lymphocytes Data Development Elderly Event Failure Family member Generations Goals Granzyme Immune response Immunity Influenza Knock-in Mouse Life Maintenance Malignant Neoplasms Mediating Mus Mutate Pattern Population Positioning Attribute Production Protein Family Proteins Resistance Role Signal Transduction Site Surface T cell response T-Cell Development T-Cell Receptor T-Lymphocyte Testing Thymocyte Development Thymocyte Selection Thymus Gland Transgenic Mice Tyrosine Virus aged base burden of illness cell killing cell mediated lymphocytolysis test immunosenescence in vivo influenzavirus inhibitor/antagonist insight killings knockin animal mortality mouse model neglect perforin prevent public health relevance response thymocyte

项目摘要

DESCRIPTION (provided by applicant): The goal for this project is to determine how cleavage of Bcl-xL by caspases contributes to cell death in vivo. Caspase cleavage of cellular substrates is a key event in mediating apoptosis. The Bcl-2 family member Bcl-xL is an inhibitor of apoptotic cell death, and can also be a substrate of caspases. Cleavage of Bcl-xL [not only abolishes its anti-death activity] but also convert Bcl-xL from a potent anti-apoptotic protein to potent pro-death molecule. Cells transfected with the N-terminally truncated Bcl-xL cleavage fragment (ΔN-Bcl-xL) display accelerated cell death. To probe the in vivo effects of Bcl-xL cleavage, a caspase-uncleavable Bcl-xL knock-in mouse was generated by mutating the two caspase cleavage sites within Bcl-xL. Interestingly, caspase-resistant Bcl-xL mice retain a healthy thymus in old age suggesting that cleavage of Bcl-xL leads to cell death that results in thymic atrophy. My preliminary data suggest that these mice may have defective positive selection (generation of a viable T-cell receptor). Therefore, we will explore the possibility that caspase-cleavage of Bcl-xL kills developing thymocytes that fail the positive selection checkpoint. By doing so, we will provide mechanistic insights into what is termed "death by neglect", the failure of thymocytes to receive survival cues. Because these mice maintain a morphologically normal thymus throughout life, I will determine if they also maintain normal immune responses to influenza virus. Influenza particularly affects the elderly, who display poor T-cell responses to the virus. This is presumed to be because of immunosenescence, in part attributed to thymic atrophy. A long-standing assumption is that thymic atrophy contributes to waning immune responses due to decreased T-cell production, but mouse models to definitively test this hypothesis have been lacking. Therefore, we are in a unique position to determine if preserved thymic function also confers protection from influenza infection in aged animals. We will critically evaluate whether thymic atrophy compromises the immune responses needed to control influenza. These studies will also address the role of thymic selection and T-cell contributions to influenza virus immunity.